Dr. Ryan Christopher Cleary, MD

Dr. Cleary practices at Summit Ambulatory Surgery Center - Bel Air in Bel Air, Maryland.

Dr. Cleary's NPI, 1013232693, was assigned on April 7, 2010. Dr. Cleary graduated from Sidney Kimmel Medical College in 2010. Dr. Cleary holds Maryland license D0083075.

Dr. Cleary's primary practice is Summit Ambulatory Surgery Center - Bel Air, at 201 Plumtree Road Suite 200, Bel Air, MD 21015. The practice phone is (410) 803-0089.

Dr. Cleary's primary practice is Summit Ambulatory Surgery Center - Bel Air in Bel Air, Maryland. Dr. Cleary is also affiliated with University of Maryland Upper Chesapeake Medical Center Bel Air. The medical group on file is Chesapeake Urology Associates. Dmand AI also links Dr. Cleary to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cleary practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Cleary's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Cleary is board certified in urology by the American Board of Urology. Dmand AI has Dr. Cleary's licenses on file in 3 states: Maryland, New York and Pennsylvania.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery and kidney stone disease among the conditions Dr. Cleary treats.

CMS data shows 6,118 Medicare services from Dr. Cleary across 32 procedure codes in 2024, for 768 Medicare patients. Medicare paid $225,284 for them.

CMS counts 768 Medicare patients who saw Dr. Cleary in 2026. The largest group is 65 to 74, with 375 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cleary's median patient age at 65, with 27% women.

In 2026, Dr. Cleary wrote 1,397 Medicare Part D claims for 353 patients. 88% of them were for generic drugs. CMS names the drug for 1,300 of them, across 21 drugs with 11 or more claims each, at $447,425 in total drug cost. In 2023, CMS named 1,014 claims across 17 drugs.

Dr. Cleary accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cleary as offering telehealth. CMS counts 28 procedures of prostate resection by Dr. Cleary, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Cleary, published from 2011 to 2016. Dr. Cleary's most frequent co-authors are Kelly A. Healy, MD, Scott G. Hubosky, MD and Leonard G. Gomella, MD.

CMS Open Payments shows 397 general payments to Dr. Cleary from 56 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 63% of the total. Intuitive Surgical, Inc. paid the most, $6,726.

Dmand AI lists 9 awards for Dr. Cleary, most recently Grand Prize Poster (In Vitro evaluation of the UroNet stone fragment retriever for PCNL) in 2013.

Dr. Cleary graduated from Sidney Kimmel Medical College in 2010.

Dr. Cleary is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.